Influence of Intragenic CCL3 Haplotypes and CCL3L Copy Number in HIV-1 Infection in a Sub-Saharan African Population

Overview

Journal Genes Immun

Date 2012 Nov 16

PMID 23151487

Citations 2

Authors

M Paximadis

D B Schramm

G E Gray

G Sherman

A Coovadia

L Kuhn

C T Tiemessen

Affiliations

Soon will be listed here.

Abstract

Two CCL3 haplotypes (HapA1 and Hap-A3) and two polymorphic positions shared by the haplotypes (Hap-2SNP (single nucleotide polymorphism)) were investigated together with CCL3L copy number (CN), for their role in HIV-1 disease. Hap-A1 was associated with protection from in utero HIV-1 infection: exposed uninfected (EU) infants had higher representation of wild type (WT)/Hap-A1 than infected infants (excluding intrapartum (IP)-infected infants), which maintained significance post maternal Nevirapine (mNVP) and viral load (MVL) correction (P=0.04; odds ratio (OR)=0.33). Mother-infant pair analyses showed the protective effect of Hap-A1 is dependent on its presence in the infant. Hap-A3 was associated with increased IP transmission: WT/Hap-A3 was increased in IP-transmitting vs non-transmitting (NT) mothers, and remained significant post mNVP and MVL correction (P=0.02; OR=3.50). This deleterious effect of Hap-A3 seemed dependent on its presence in the mother. Hap-2SNP was associated with lower CD4 count in the NT mothers (P=0.03). CCL3 Hap-A1 was associated with high CCL3L CN in total (P=0.001) and EU infants (P=0.006); the effect was not additive, however, having either Hap-A1 or high CCL3L CN was more significantly (P=0.0008) associated with protection from in utero infection than Hap-A1 (P=0.028) or high CCL3L CN (P=0.002) alone. Linkage disequilibrium between Hap-A1 and high CCL3L CN appears unlikely given that a Nigerian population showed an opposite relationship.

Citing Articles

The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals.

Dias B, Paximadis M, Martinson N, Chaisson R, Ebrahim O, Tiemessen C Infect Genet Evol. 2020; 80:104216.

PMID: 32006707 PMC: 8752124. DOI: 10.1016/j.meegid.2020.104216.

RICH2 is implicated in viraemic control of HIV-1 in black South African individuals.

Paximadis M, Ngqobe R, Chaisson R, Martinson N, Tiemessen C Infect Genet Evol. 2017; 49:78-87.

PMID: 28069446 PMC: 5330811. DOI: 10.1016/j.meegid.2017.01.007.

References

McCarroll S, Kuruvilla F, Korn J, Cawley S, Nemesh J, Wysoker A . Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet. 2008; 40(10):1166-74. DOI: 10.1038/ng.238. View

Clark A . The role of haplotypes in candidate gene studies. Genet Epidemiol. 2004; 27(4):321-33. DOI: 10.1002/gepi.20025. View

Lewontin R . The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models. Genetics. 1964; 49(1):49-67. PMC: 1210557. DOI: 10.1093/genetics/49.1.49. View

Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G . The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science. 2005; 307(5714):1434-40. DOI: 10.1126/science.1101160. View

Nakao M, Nomiyama H, Shimada K . Structures of human genes coding for cytokine LD78 and their expression. Mol Cell Biol. 1990; 10(7):3646-58. PMC: 360801. DOI: 10.1128/mcb.10.7.3646-3658.1990. View

Feng Y, Broder C, Kennedy P, BERGER E . HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996; 272(5263):872-7. DOI: 10.1126/science.272.5263.872. View

Menten P, Struyf S, Schutyser E, Wuyts A, De Clercq E, Schols D . The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. J Clin Invest. 1999; 104(4):R1-5. PMC: 481049. DOI: 10.1172/JCI7318. View

Hirashima M, Ono T, Nakao M, Nishi H, Kimura A, Nomiyama H . Nucleotide sequence of the third cytokine LD78 gene and mapping of all three LD78 gene loci to human chromosome 17. DNA Seq. 1992; 3(4):203-12. DOI: 10.3109/10425179209034019. View

Gauduin M, Glickman R, Means R, Johnson R . Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV. J Virol. 1998; 72(8):6315-24. PMC: 109771. DOI: 10.1128/JVI.72.8.6315-6324.1998. View

10.

Guo S, Thompson E . Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 1992; 48(2):361-72. View

11.

Kuhn L, Schramm D, Donninger S, Meddows-Taylor S, Coovadia A, Sherman G . African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS. 2007; 21(13):1753-61. PMC: 2386991. DOI: 10.1097/QAD.0b013e3282ba553a. View

12.

Lu Y, Xin K, Hamajima K, Tsuji T, Aoki I, Yang J . Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1. Clin Exp Immunol. 1999; 115(2):335-41. PMC: 1905150. DOI: 10.1046/j.1365-2249.1999.00793.x. View

13.

Liu S, Yao L, Ding D, Zhu H . CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis. PLoS One. 2011; 5(12):e15778. PMC: 3012711. DOI: 10.1371/journal.pone.0015778. View

14.

Zhao W, Pahar B, Borda J, Alvarez X, Sestak K . A decline in CCL3-5 chemokine gene expression during primary simian-human immunodeficiency virus infection. PLoS One. 2007; 2(8):e726. PMC: 1933601. DOI: 10.1371/journal.pone.0000726. View

15.

Campbell C, Sampas N, Tsalenko A, Sudmant P, Kidd J, Malig M . Population-genetic properties of differentiated human copy-number polymorphisms. Am J Hum Genet. 2011; 88(3):317-32. PMC: 3059424. DOI: 10.1016/j.ajhg.2011.02.004. View

16.

Carpenter D, McIntosh R, Pleass R, Armour J . Functional effects of CCL3L1 copy number. Genes Immun. 2012; 13(5):374-9. PMC: 3409875. DOI: 10.1038/gene.2012.5. View

17.

Dolan M, Kulkarni H, Camargo J, He W, Smith A, Anaya J . CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol. 2007; 8(12):1324-36. DOI: 10.1038/ni1521. View

18.

Townson J, Barcellos L, Nibbs R . Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol. 2002; 32(10):3016-26. DOI: 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D. View

19.

Conrad D, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y . Origins and functional impact of copy number variation in the human genome. Nature. 2009; 464(7289):704-12. PMC: 3330748. DOI: 10.1038/nature08516. View

20.

Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G . Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A. 2001; 98(9):5199-204. PMC: 33187. DOI: 10.1073/pnas.091056898. View